Cargando…

Prime editing strategies to mediate exon skipping in DMD gene

Duchenne muscular dystrophy is a rare and lethal hereditary disease responsible for progressive muscle wasting due to mutations in the DMD gene. We used the CRISPR-Cas9 Prime editing technology to develop different strategies to correct frameshift mutations in DMD gene carrying the deletion of exon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Happi Mbakam, Cedric, Roustant, Jeanne, Rousseau, Joel, Yameogo, Pouire, Lu, Yaoyao, Bigot, Anne, Mamchaoui, Kamel, Mouly, Vincent, Lamothe, Gabriel, Tremblay, Jacques P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248452/ https://www.ncbi.nlm.nih.gov/pubmed/37305116 http://dx.doi.org/10.3389/fmed.2023.1128557

Ejemplares similares

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy
por: Happi Mbakam, Cédric, et al.
Publicado: (2022)

Small-molecule inhibitors of proteasome increase CjCas9 protein stability
por: Yaméogo, Pouiré, et al.
Publicado: (2023)

Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012)

Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches
por: Lorain, Stéphanie, et al.
Publicado: (2013)

Skipping Multiple Exons to Treat DMD—Promises and Challenges
por: Aslesh, Tejal, et al.
Publicado: (2018)

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
por: Gapinske, Michael, et al.
Publicado: (2023)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
por: Wang, Peipei, et al.
Publicado: (2022)

Repurposing Pathogenic Variants of DMD Gene and its Isoforms for DMD Exon Skipping Intervention
por: Tyagi, Rahul, et al.
Publicado: (2019)

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
por: Lattanzi, Annalisa, et al.
Publicado: (2017)

Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach
por: Marchesi, Elena, et al.
Publicado: (2021)

Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49
por: Abaji, Mario, et al.
Publicado: (2022)

What Can We Learn From Clinical Trials of Exon Skipping for DMD?
por: Lu, Qi-long, et al.
Publicado: (2014)

A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
por: Hiller, Monika, et al.
Publicado: (2018)

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
por: Saoudi, Amel, et al.
Publicado: (2023)

Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1
por: Shiba, Naoko, et al.
Publicado: (2023)

Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases
por: Lu, Yaoyao, et al.
Publicado: (2022)

A Genotype-Phenotype Correlation Study of Exon Skip-Equivalent In-Frame Deletions and Exon Skip-Amenable Out-of-Frame Deletions across the DMD Gene to Simulate the Effects of Exon-Skipping Therapies: A Meta-Analysis
por: Anwar, Saeed, et al.
Publicado: (2021)

Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
por: Akpulat, Ugur, et al.
Publicado: (2018)

Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy
por: Okubo, Mariko, et al.
Publicado: (2020)

Insertion of the protective APP A673T mutation by CRISPR/Cas9 base editing or PRIME editing.
por: Tremblay, Jacques, et al.
Publicado: (2021)

Prevention of early-onset cardiomyopathy in Dmd exon 52–54 deletion mice by CRISPR-Cas9-mediated exon skipping
por: Rok, Matthew, et al.
Publicado: (2023)

DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
por: Goossens, Remko, et al.
Publicado: (2023)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
por: Wang, Derek W., et al.
Publicado: (2018)

Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy
por: Aupy, Philippine, et al.
Publicado: (2019)

The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
por: Gargaun, Elena, et al.
Publicado: (2021)

Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs
por: Kita, Yuto, et al.
Publicado: (2023)

FUBP1: a new protagonist in splicing regulation of the DMD gene
por: Miro, Julie, et al.
Publicado: (2015)

Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts
por: Lee, Joshua, et al.
Publicado: (2018)

Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients’ Cells
por: Barthélémy, Florian, et al.
Publicado: (2015)

ExonSkipDB: functional annotation of exon skipping event in human
por: Kim, Pora, et al.
Publicado: (2020)

Genome editing through large insertion leads to the skipping of targeted exon
por: Uddin, Borhan, et al.
Publicado: (2015)

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
por: Betts, Corinne, et al.
Publicado: (2012)

Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study
por: Brogna, Claudia, et al.
Publicado: (2023)

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
por: Mou, Haiwei, et al.
Publicado: (2017)

Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
por: Aupy, Philippine, et al.
Publicado: (2020)

Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models
por: Barthélémy, Florian, et al.
Publicado: (2019)

Frameshift indels introduced by genome editing can lead to in-frame exon skipping
por: Lalonde, Simon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_07ans4v50lls2eia0l43pmjfen